| 創建日期 | 上市日期 | 董事長 | 總經理 |
|---|---|---|---|
| 93/09/27 | 106/12/05 | 賴家德 | 賴家德 |
| EPS | 本益比 | 股價淨值比 | 現金殖利率 |
| 0.13(Q2) | 52.46 | 1.8 | 6.81% |
| 實收資本額 | 已發行普通股 | ||
| 1,148,692,390 | 114,869,239 | ||
| 主要經營業務 | |||
| 醫療器材製造業醫療器材設備業醫療器材零售業 | |||
| 公司網址 | |||
| okbiotech.com | |||
訊映(4155) 月營收報表
| 年度/月份 | 營業收入（單位：千元） | 累計營業收入（單位：千元） | |||||
|---|---|---|---|---|---|---|---|
| 單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 | |
| 2023/08 | 96,208 | 118,701 | 4.3% | -18.9% | 828,841 | 1,055,728 | -21.5% |
| 2023/07 | 92,213 | 84,005 | -37.3% | 9.8% | 732,633 | 937,027 | -21.8% |
| 2023/06 | 147,055 | 157,787 | 39.2% | -6.8% | 640,420 | 853,022 | -24.9% |
| 2023/05 | 105,662 | 162,245 | 58.5% | -34.9% | 493,365 | 695,235 | -29% |
| 2023/04 | 66,672 | 115,861 | -44.6% | -42.5% | 387,703 | 532,990 | -27.3% |
| 2023/03 | 120,322 | 170,372 | 119.7% | -29.4% | 321,031 | 417,129 | -23% |
| 2023/02 | 54,763 | 101,142 | -62.5% | -45.8% | 200,709 | 246,757 | -18.7% |
| 2023/01 | 145,946 | 145,615 | 124.1% | 0.2% | 145,946 | 145,615 | 0.2% |
| 2022/12 | 65,113 | 147,082 | -62% | -55.7% | 1,483,523 | 1,263,378 | 17.4% |
| 2022/11 | 171,351 | 109,778 | 100% | 56.1% | 1,418,410 | 1,116,296 | 27.1% |
| 2022/10 | 85,666 | 100,972 | -18.9% | -15.1% | 1,247,059 | 1,006,518 | 23.9% |
| 2022/09 | 105,665 | 108,962 | -11% | -3% | 1,161,393 | 905,546 | 28.3% |
| 2022/08 | 118,701 | 74,287 | 41.3% | 59.8% | 1,055,728 | 796,584 | 32.5% |
| 2022/07 | 84,005 | 125,842 | -46.8% | -33.2% | 937,027 | 722,297 | 29.7% |
| 2022/06 | 157,787 | 88,984 | -2.7% | 77.3% | 853,022 | 596,455 | 43% |
| 2022/05 | 162,245 | 126,531 | 40% | 28.2% | 695,235 | 507,471 | 37% |
| 2022/04 | 115,861 | 84,995 | -32% | 36.3% | 532,990 | 380,940 | 39.9% |
| 2022/03 | 170,372 | 88,240 | 68.4% | 93.1% | 417,129 | 295,945 | 40.9% |
| 2022/02 | 101,142 | 106,005 | -30.5% | -4.6% | 246,757 | 207,705 | 18.8% |
| 2022/01 | 145,615 | 101,700 | -1% | 43.2% | 145,615 | 101,700 | 43.2% |
| 2021/12 | 147,082 | 126,795 | 34% | 16% | 1,263,378 | 1,484,387 | -14.9% |
| 2021/11 | 109,778 | 120,532 | 8.7% | -8.9% | 1,116,296 | 1,357,592 | -17.8% |
| 2021/10 | 100,972 | 205,049 | -7.3% | -50.8% | 1,006,518 | 1,237,060 | -18.6% |
| 2021/09 | 108,962 | 129,401 | 46.7% | -15.8% | 905,546 | 1,032,011 | -12.3% |
| 2021/08 | 74,287 | 107,176 | -41% | -30.7% | 796,584 | 902,610 | -11.7% |
| 2021/07 | 125,842 | 105,346 | 41.4% | 19.5% | 722,297 | 795,434 | -9.2% |
| 2021/06 | 88,984 | 104,273 | -29.7% | -14.7% | 596,455 | 690,088 | -13.6% |
| 2021/05 | 126,531 | 104,787 | 48.9% | 20.8% | 507,471 | 585,815 | -13.4% |
| 2021/04 | 84,995 | 110,169 | -3.7% | -22.9% | 380,940 | 481,028 | -20.8% |
| 2021/03 | 88,240 | 121,803 | -16.8% | -27.5% | 295,945 | 370,859 | -20.2% |
| 2021/02 | 106,005 | 101,439 | 4.2% | 4.5% | 207,705 | 249,056 | -16.6% |
| 2021/01 | 101,700 | 147,616 | -19.8% | -31.1% | 101,700 | 147,616 | -31.1% |
| 2020/12 | 126,795 | 134,622 | 5.2% | -5.8% | 1,484,387 | 1,239,995 | 19.7% |
| 2020/11 | 120,532 | 118,386 | -41.2% | 1.8% | 1,357,592 | 1,105,373 | 22.8% |
| 2020/10 | 205,049 | 120,663 | 58.5% | 69.9% | 1,237,060 | 986,987 | 25.3% |
| 2020/09 | 129,401 | 103,968 | 20.7% | 24.5% | 1,032,011 | 866,324 | 19.1% |
訊映(4155) 歷年營收季增率
| 年度/季別 | 營收季增率 | 近4季營收季增率 | 年度/季別 | 營收季增率 | 近4季營收季增率 |
|---|---|---|---|---|---|
| 2023Q2 | -0.51% | -8.40% | 2020Q3 | 7.11% | 3.75% |
| 2023Q1 | -0.34% | -6.48% | 2020Q2 | -13.92% | 1.95% |
| 2022Q4 | 4.46% | -2.35% | 2020Q1 | -0.75% | 7.17% |
| 2022Q3 | -29.26% | -0.05% | 2019Q4 | 28.36% | 6.14% |
| 2022Q2 | 4.50% | 9.78% | 2019Q3 | -0.74% | 2.13% |
| 2022Q1 | 16.57% | 9.59% | 2019Q2 | 4.03% | 3.34% |
| 2021Q4 | 15.77% | -6.96% | 2019Q1 | -6.64% | -1.15% |
| 2021Q3 | 2.86% | -2.36% | 2018Q4 | 13.19% | 3.91% |
| 2021Q2 | 1.54% | -1.33% | 2018Q3 | 4.10% | -6.65% |
| 2021Q1 | -34.58% | -5.05% | 2018Q2 | -13.07% | -6.72% |
| 2020Q4 | 32.30% | 5.60% | 2018Q1 | 13.45% | 0.34% |
評論0